Diverse perspectives on science and medicine
0000-0003-0319-5416Synthetic biology is moving at a rapid pace, and regulations will need to keep up to allow useful technologies to hit the market while maintaining a high standard of safety. Since most policymakers are not experts
After briefly fading from the media spotlight, CRISPR, the genome-engineering tool that caused widespread consternation at the end of 2015, when a Chinese group first reported applying the technique in (non-viable) human embryos, is staging a comeback in
When we decided to crowdsource a review of the year from the synthetic biology community we weren’t sure what the response would be – but it has been fantastic! So good in fact, that we
“What will we do with this?” is a question we ask each time a significant new product or technology is developed. In some cases, the question is literal: Lasers were considered a “solution looking for a problem.”
One of the primary points of emphasis at iGEM is encouraging teams to think about the consequences of their science. As part of each presentation, the students discuss potential implications of their work in terms
